Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02655536
Brief Title: Bevacizumab and Erlotinib in Lung Cancer With Brain Metastases, a Phase II Trial (BRILLIANT)

First Submitted : December 24, 2015
First Submitted that Met QC Criteria : January 12, 2016
First Posted : January 14, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : July 9, 2018
Last Update Posted : July 10, 2018